To identify biomarkers associated with the transfer of diabetes combined with cancer in human genes using bioinformatics analysis

Author:

Li Yiting1,Gu Shinong1,Li Xuanwen2,Huang Qing1ORCID

Affiliation:

1. College of Environment and Public Health, Xiamen Huaxia University, Xiamen, P.R. China

2. Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Japan.

Abstract

Currently, the incidence of diabetes mellitus is increasing rapidly, particularly in China, and its pathogenesis is still unclear. The goal of this study was to find meaningful biomarkers of metastasis in patients with diabetes and cancer using bioinformatic analysis in order to predict gene expression and prognostic importance for survival. We used the Differentially Expressed Gene, Database for Annotation Visualization and Integrated Discovery, and Gene Set Enrichment Analyses databases, as well as several bioinformatics tools, to explore the key genes in diabetes. Based on the above database, we ended up with 10 hub genes (FOS, ATF3, JUN, EGR1, FOSB, JUNB, BTG2, EGR2, ZFP36, and NR4A2). A discussion of the 10 critical genes, with extensive literature mentioned to validate the association between the 10 key genes and patients with diabetes and cancer, to demonstrate the importance of gene expression and survival prognosis. This study identifies several biomarkers associated with diabetes and cancer development and metastasis that may provide novel therapeutic targets for diabetes combined with cancer patients.

Funder

the Natural Science Foundation of Xiamen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference47 articles.

1. Progress on research and development in diabetes mellitus.;Zhang;Yi Chuan,2022

2. The impact of diabetes on vascular disease: progress from the perspective of epidemics and treatments.;Liu;J Diabetes Res,2022

3. Mortality and years of life lost in diabetes mellitus and its subcategories in China and Its Provinces, 2005-2020.;Wang;J Diabetes Res,2022

4. Report on Cardiovascular Health and Diseases in China 2021: an updated summary.;Biomed Environ Sci,2022

5. C-peptide determination in the diagnosis of type of diabetes and its management: a clinical perspective.;Maddaloni;Diabetes Obes Metab,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3